|
Pharmacokinetics and relative bioavailability of glipizide tablets andcapsules in healthy volunteers
|
|
|
格列吡嗪在健康志愿者体内的药物动力学及相对生物利用度 |
|
Pharmacokinetics and relative bioavailability of lovastatin capsule
|
|
|
洛伐他汀胶囊药动学与相对生物利用度 |
|
Pharmacokinetics and relative bioavailability of nimodipine in healthy adults
|
|
|
尼莫地平在健康人体的药物动力学与相对生物利用度 |
|
Pharmacokinetics and relative bioavailability of rifapentine
|
|
|
利福喷丁软胶囊的药动学和相对生物利用度 |
|
Pharmacokinetics and relative bioavailability of roxithromycin capsule
|
|
|
罗红霉素胶囊的药动学与相对生物利用度 |
|
Pharmacokinetics and relative bioavailability of valaciclovir hydrochloride tablet
|
|
|
盐酸伐昔洛韦片的药动学与生物利用度 |
|
Pharmacokinetics and tissue distribution of human recombinant interleukin-2 in mice
|
|
|
基因重组人白细胞介素-2在小鼠的药物动力学和分布(英文) |
|
Pharmacokinetics and tissue distribution of recombinant human interleukin-3 in mice
|
|
|
重组人白细胞介素－3在小鼠体内的药代动力学及组织分布 |
|
Pharmacokinetics and tissues distribution of Gatifloxacin in dogs with liver damaged
|
|
|
加替沙星在肝损害模型家犬体内药代动力学和组织分布研究 |
|
Pharmacokinetics and toxicity of amygdalin
|
|
|
苦杏仁甙药物动力学及其毒理初步研究 |
|
Pharmacokinetics investigation of 5-fluorouracil after three routes of administration
|
|
|
5-氟尿嘧啶三种给药途径和药代动力学 |
